IUGR, or intrauterine growth restriction, is a condition in which a baby fails to grow to its expected size during pregnancy. It affects up to 10% of pregnancies and is formally defined as an estimated fetal weight or abdominal circumference falling below the 10th percentile for gestational age. While some small babies are perfectly healthy, IUGR specifically refers to cases where something is preventing the baby from reaching its genetic growth potential.
IUGR vs. Small for Gestational Age
These two terms are often confused, but they describe different things. “Small for gestational age” (SGA) is a broader label applied to any newborn weighing below the 10th percentile for their gestational age. That group includes babies with IUGR, but it also includes babies who are constitutionally small, meaning they’re just naturally petite because of their parents’ size or ethnicity, and are otherwise completely healthy.
IUGR is the clinical concern underneath. It means some factor, whether related to the placenta, the mother’s health, or the baby itself, is actively limiting growth. The distinction matters because a constitutionally small baby needs no special intervention, while a baby with true growth restriction requires close monitoring and sometimes early delivery.
Symmetric vs. Asymmetric Growth Restriction
Growth restriction takes two forms, and identifying which one is present helps point toward the underlying cause.
Symmetric IUGR means the baby’s entire body is proportionally small, including the head, abdomen, and limbs. This pattern tends to develop early in pregnancy and is more commonly linked to chromosomal disorders or infections the baby contracts in the womb. Because the insult begins during the period of rapid cell division, all organs are affected equally.
Asymmetric IUGR is more common and reflects a baby that is actively being undernourished. The baby redirects its limited blood flow and energy toward protecting the brain and heart at the expense of other organs. On ultrasound, this shows up as a normal-sized head but a small abdominal circumference (because the liver shrinks), thin limbs (from reduced muscle mass), and less body fat. This pattern typically results from problems with the placenta and tends to appear later in pregnancy. If the cause persists long enough or becomes severe, the baby may lose the ability to compensate and the growth restriction can become symmetric.
What Causes IUGR
The causes fall into three categories: placental problems, maternal health conditions, and issues with the baby itself.
Placental insufficiency is the most common driver. Early in pregnancy, the blood vessels supplying the placenta are supposed to remodel so they can deliver enough blood to the growing baby. When that remodeling fails, the placenta doesn’t receive adequate blood flow. Microscopic damage builds up in the placental tissue, reducing the surface area available for delivering oxygen and nutrients. When IUGR occurs alongside preeclampsia, the placenta also sheds inflammatory particles into the mother’s bloodstream, which can damage her blood vessel lining.
On the maternal side, chronic conditions like high blood pressure, diabetes, and kidney disease all raise the risk. Infections passed from mother to baby, including rubella, syphilis, cytomegalovirus, and toxoplasmosis, can directly impair fetal growth. Modifiable risk factors also play a role: smoking, drug and alcohol use, poor nutrition, and not gaining enough weight during pregnancy all increase the likelihood of IUGR. Even living at high altitude is associated with lower birth weight.
Fetal causes include chromosomal abnormalities such as Down syndrome and other genetic conditions that affect growth from the earliest stages of development.
How IUGR Is Detected
Most cases are initially suspected during routine prenatal care when the uterus measures smaller than expected for the stage of pregnancy. An ultrasound then confirms or rules out growth restriction by estimating the baby’s weight and measuring the abdominal circumference.
Once IUGR is diagnosed, the focus shifts to understanding how well the baby is coping. Doppler ultrasound, which measures blood flow through specific vessels, plays a central role. The most important measurement is blood flow through the umbilical artery. As placental function worsens, resistance in this artery increases progressively. In advanced cases, forward blood flow at the end of each heartbeat disappears entirely or even reverses, a sign of severe placental failure.
Doctors also check blood flow in the baby’s brain arteries. When a baby is deprived of oxygen, the blood vessels in its brain dilate to pull in more blood, a protective response called the “brain-sparing effect.” This keeps the brain oxygenated longer but signals that the baby is under significant stress. In the most severe cases, changes in blood flow through a small vessel near the heart called the ductus venosus indicate the baby’s cardiovascular system is struggling to compensate for extreme oxygen deprivation.
Ongoing Monitoring
A pregnancy with confirmed IUGR requires frequent surveillance using multiple tools in combination. Beyond Doppler studies, providers use the biophysical profile (BPP), which scores five aspects of fetal well-being: muscle tone, body movement, breathing movements, amniotic fluid volume, and heart rate reactivity. Each component receives a score, and the total correlates with the baby’s blood pH level. A score of 4 or below is associated with significant acid buildup in the baby’s blood and typically prompts delivery.
Electronic fetal heart rate monitoring (cardiotocography) adds another layer. Clinical guidelines recommend using these tools together rather than relying on any single test, because each captures a slightly different aspect of how the baby is tolerating the growth restriction. The frequency of monitoring depends on severity. Early-onset IUGR, which begins before 32 weeks and accounts for roughly 0.5 to 1% of pregnancies, requires especially close watch because these babies face a longer stretch of compromised growth before they’re mature enough for delivery.
When Delivery Is Recommended
The central tension in managing IUGR is balancing two competing risks: the danger of leaving a struggling baby in a deteriorating environment versus the risks of delivering a premature baby. There is no single gestational age cutoff. Instead, the decision hinges on the results of ongoing monitoring.
When Doppler studies show severely abnormal blood flow patterns, or when the biophysical profile drops to 4 or below, delivery is generally recommended if the pregnancy has reached at least 26 weeks. Before that threshold, the decision is more complex and depends on individual circumstances. In milder cases with stable monitoring results, the goal is to continue the pregnancy as long as safely possible to give the baby more time to mature, particularly for lung development.
Risks for the Baby After Birth
Babies born with growth restriction face several immediate challenges. Their smaller size and reduced fat stores make them vulnerable to drops in body temperature. They are also prone to low blood sugar because they have less stored energy to draw on. Some develop an abnormally high concentration of red blood cells, which the body produces in response to chronic oxygen deprivation in the womb, and this can cause its own complications by thickening the blood.
The severity of these problems depends on how early the growth restriction began, how severe it was, and how premature the baby is at delivery. Most growth-restricted babies who are delivered at or near full term do well with supportive care in the first days of life.
Long-Term Health Effects
The consequences of IUGR can extend well beyond infancy. Research tracking adults who were born very small has found measurable differences in cardiovascular and metabolic health decades later. In one study published in the Journal of Clinical Endocrinology & Metabolism, adults born at very low birth weight had systolic blood pressure averaging 7 points higher than controls, along with higher blood sugar markers, greater insulin resistance, and lower levels of protective HDL cholesterol. Adults born small for gestational age at full term also showed higher waist circumference and elevated LDL cholesterol compared to normal-weight peers.
At least one component of metabolic syndrome (a cluster of risk factors including central obesity, high blood pressure, abnormal cholesterol, and elevated blood sugar) was present in 72% of very low birth weight adults by their mid-twenties, compared to 55% of controls. The differences were especially pronounced in women. Researchers also found higher levels of homocysteine, an amino acid linked to cardiovascular risk, in both low birth weight groups, along with a connection between metabolic problems and reduced bone quality, suggesting higher fracture risk later in life.
These findings don’t mean every baby born with IUGR will develop heart disease or diabetes. They do suggest that people born growth-restricted may benefit from proactive screening for cardiovascular and metabolic risk factors as they move through adulthood.